Form 4: Repligen CEO's Tax-Related Stock Sale
Insider Transaction Report
Repligen CEO Olivier Loeillot disposed of 1,248 shares of common stock to cover tax obligations related to restricted stock units.
Summary
- Olivier Loeillot, Chief Executive Officer and Director of Repligen Corp (RGEN), reported a disposition of common stock.
- On October 2, 2025, 1,248 shares of Repligen common stock were disposed of at a price of $145.23 per share.
- This transaction was identified as a tax withholding (Code F), representing shares withheld by the Issuer to satisfy tax obligations upon the release of restricted stock units.
- Following this reported transaction, Olivier Loeillot directly beneficially owns 42,939 shares of Repligen common stock.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary tax-related stock disposition by an executive, which is a neutral event and does not reflect positive or negative sentiment regarding the company's performance or outlook.
Industry Context
This filing details a routine insider transaction for tax purposes and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine, non-discretionary tax-related transaction by an executive, not a discretionary sale indicating a change in confidence.
Key Dates
| Date | Description |
|---|---|
| 10/02/2025 | Date of transaction (disposition of shares) |
| 10/06/2025 | Date the Form 4 was signed by Attorney in Fact |
Recommendation
holdThis Form 4 filing details a routine, non-discretionary disposition of shares by the CEO for tax withholding purposes related to restricted stock unit vesting. It does not provide any new fundamental information about Repligen's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on prior analysis of the company's fundamentals.
Keywords
Repligen, RGEN, Insider Transaction, CEO, Stock Sale, Tax Withholding, Form 4, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.